NYSE:NVS - New York Stock Exchange, Inc. - US66987V1098 - ADR - Currency: USD
We assign a fundamental rating of 7 out of 10 to NVS. NVS was compared to 198 industry peers in the Pharmaceuticals industry. NVS gets an excellent profitability rating and is at the same time showing great financial health properties. A decent growth rate in combination with a cheap valuation! Better keep an eye on NVS. These ratings could make NVS a good candidate for value and quality investing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 12.87% | ||
ROE | 33.51% | ||
ROIC | 23.17% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 32.76% | ||
PM (TTM) | 24.15% | ||
GM | 75.69% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.61 | ||
Debt/FCF | 2.1 | ||
Altman-Z | 3.72 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.79 | ||
Quick Ratio | 0.61 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 13.56 | ||
Fwd PE | 12.42 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 14.99 | ||
EV/EBITDA | 10.54 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 3.87% |
NYSE:NVS (5/23/2025, 2:41:08 PM)
112.705
+0.2 (+0.18%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 3.87% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 13.56 | ||
Fwd PE | 12.42 | ||
P/S | 4.18 | ||
P/FCF | 14.99 | ||
P/OCF | 11.72 | ||
P/B | 5.8 | ||
P/tB | N/A | ||
EV/EBITDA | 10.54 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 12.87% | ||
ROE | 33.51% | ||
ROCE | 25.54% | ||
ROIC | 23.17% | ||
ROICexc | 25.87% | ||
ROICexgc | 181.05% | ||
OM | 32.76% | ||
PM (TTM) | 24.15% | ||
GM | 75.69% | ||
FCFM | 27.88% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.61 | ||
Debt/FCF | 2.1 | ||
Debt/EBITDA | 0.99 | ||
Cap/Depr | 70.27% | ||
Cap/Sales | 7.8% | ||
Interest Coverage | 18.56 | ||
Cash Conversion | 81.35% | ||
Profit Quality | 115.46% | ||
Current Ratio | 0.79 | ||
Quick Ratio | 0.61 | ||
Altman-Z | 3.72 |